Alkermes
ALKS
#3093
Rank
โ‚ฌ4.18 B
Marketcap
25,35ย โ‚ฌ
Share price
0.75%
Change (1 day)
-14.85%
Change (1 year)

Alkermes (ALKS) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.95 Billion

According to Alkermes's latest financial reports the company has โ‚ฌ0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alkermes - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.72 B3.23%
2023-12-31โ‚ฌ0.69 B23.35%
2022-12-31โ‚ฌ0.56 B19.78%
2021-12-31โ‚ฌ0.47 B-8.28%
2020-12-31โ‚ฌ0.51 B8.11%
2019-12-31โ‚ฌ0.47 B1.3%
2018-12-31โ‚ฌ0.47 B30.48%
2017-12-31โ‚ฌ0.36 B-23.57%
2016-12-31โ‚ฌ0.47 B-3.35%
2015-12-31โ‚ฌ0.48 B-5.75%
2014-12-31โ‚ฌ0.51 B
2013-03-31โ‚ฌ0.17 B21.08%
2012-03-31โ‚ฌ0.14 B0.4%
2011-03-31โ‚ฌ0.14 B-31.36%
2010-03-31โ‚ฌ0.20 B-15.26%
2009-03-31โ‚ฌ0.24 B13.14%
2008-03-31โ‚ฌ0.21 B-18.03%
2007-03-31โ‚ฌ0.26 B5.98%
2006-03-31โ‚ฌ0.24 B58.48%
2005-03-31โ‚ฌ0.15 B34.8%
2004-03-31โ‚ฌ0.11 B-7.4%
2003-03-31โ‚ฌ0.12 B-27.99%
2002-03-31โ‚ฌ0.17 B-40.02%
2001-03-31โ‚ฌ0.29 B-17.44%
2000-03-31โ‚ฌ0.35 B132.99%
1999-03-31โ‚ฌ0.15 B-7.58%
1998-03-31โ‚ฌ0.16 B127.74%
1997-03-31โ‚ฌ71.87 M163.47%
1996-03-31โ‚ฌ27.28 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Acorda Therapeutics
ACOR
โ‚ฌ8.04 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 1,385.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 1,570.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 1,248.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ7.02 B 636.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B 98.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.97 B 840.67%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
โ‚ฌ8.37 B 777.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland